Skip to main content
. 2021 Aug 26;13(8):1094–1111. doi: 10.4252/wjsc.v13.i8.1094

Table 6.

Frequency of use of iMSC surface markers

Positive CSM
%
Negative CSM
%
CD73 18.1 CD45 24.5
CD105 17.1 CD34 23.0
CD90 15.7 CD14 8.6
CD44 12.5 CD31 7.2
CD29 9.3 HLA-DR 5.8
CD166 6.9 CD11b 5.0
CD146 3.7 CD133 2.9
CD49(a) 2.8 TRA181 2.9
HLA-ABC 2.3 CD19 2.2
CD49(e) 1.9 CD24 2.2
CD106 1.4 CD3 1.4
CD271 1.4 CD40 1.4
CD49(d) 0.9 CD56 1.4
CD140alpha 0.9 CD80 1.4
Sca1 0.9 CD86 1.4
CD33 0.5 Oct3/4 1.4
CD49(f) 0.5 CD4 0.7
CD54 0.5 CD20 0.7
CD71 0.5 CD79a 0.7
CD140(b) 0.5 CD117 0.7
CD144 0.5 CD309 0.7
CD172alpha 0.5 Sox2 0.7
αSMA+ 0.5 TRA-160 0.7
Stro1 0.5 TRA-161 0.7
TRA180 0.7
SSEA-4 0.7

Positive and negative surface expression markers found in mesenchymal stem cells are listed together with the frequency of findings (%) in the reviewed studies (n = 44). CD: Cluster of differentiation; CSM: Cell surface marker; HLA: Human leukocyte antigen; SSEA: Stage specific embryonic antigen; TRA: Teratocarcinoma surface antigen.